Deroy & Devereaux Private Investment Counsel Inc. Sells 57,457 Shares of Oracle Corporation $ORCL

Deroy & Devereaux Private Investment Counsel Inc. reduced its position in shares of Oracle Corporation (NYSE:ORCLFree Report) by 29.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 135,262 shares of the enterprise software provider’s stock after selling 57,457 shares during the period. Oracle makes up 1.6% of Deroy & Devereaux Private Investment Counsel Inc.’s portfolio, making the stock its 21st biggest holding. Deroy & Devereaux Private Investment Counsel Inc.’s holdings in Oracle were worth $29,572,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Redmont Wealth Advisors LLC purchased a new position in shares of Oracle during the first quarter worth about $27,000. Inlight Wealth Management LLC bought a new stake in Oracle during the first quarter valued at approximately $28,000. Iron Horse Wealth Management LLC grew its stake in Oracle by 284.9% in the 1st quarter. Iron Horse Wealth Management LLC now owns 204 shares of the enterprise software provider’s stock worth $29,000 after buying an additional 151 shares in the last quarter. Legend Financial Advisors Inc. bought a new position in shares of Oracle in the 2nd quarter worth $34,000. Finally, HighMark Wealth Management LLC bought a new position in shares of Oracle in the 2nd quarter worth $38,000. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Oracle Stock Performance

NYSE:ORCL opened at $299.33 on Wednesday. The company has a debt-to-equity ratio of 3.33, a quick ratio of 0.62 and a current ratio of 0.62. Oracle Corporation has a fifty-two week low of $118.86 and a fifty-two week high of $345.72. The firm has a market cap of $853.32 billion, a PE ratio of 69.29, a price-to-earnings-growth ratio of 3.31 and a beta of 1.53. The business has a 50 day moving average price of $268.67 and a 200-day moving average price of $212.52.

Oracle (NYSE:ORCLGet Free Report) last posted its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). The firm had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. Oracle had a net margin of 21.08% and a return on equity of 72.93%. The company’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.39 earnings per share. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Equities research analysts predict that Oracle Corporation will post 5 earnings per share for the current year.

Oracle Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Investors of record on Thursday, October 9th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Thursday, October 9th. This represents a $2.00 annualized dividend and a dividend yield of 0.7%. Oracle’s dividend payout ratio (DPR) is presently 46.30%.

Analyst Ratings Changes

ORCL has been the subject of a number of research analyst reports. BMO Capital Markets set a $355.00 price objective on shares of Oracle and gave the stock an “outperform” rating in a report on Monday. Melius Research lifted their price target on Oracle from $270.00 to $370.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Oppenheimer reiterated an “outperform” rating on shares of Oracle in a report on Wednesday, June 18th. Stifel Nicolaus raised their price objective on Oracle from $250.00 to $350.00 and gave the company a “buy” rating in a report on Wednesday, September 10th. Finally, Rothschild & Co Redburn assumed coverage on Oracle in a research note on Thursday, September 25th. They issued a “sell” rating and a $175.00 target price for the company. Three research analysts have rated the stock with a Strong Buy rating, twenty-seven have issued a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $307.00.

Read Our Latest Stock Report on ORCL

Insider Activity at Oracle

In other news, insider Clayton M. Magouyrk sold 21,241 shares of the business’s stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $297.11, for a total transaction of $6,310,913.51. Following the transaction, the insider directly owned 78,000 shares of the company’s stock, valued at approximately $23,174,580. The trade was a 21.40% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Michael D. Sicilia sold 33,845 shares of the company’s stock in a transaction that occurred on Tuesday, September 23rd. The shares were sold at an average price of $321.16, for a total value of $10,869,660.20. Following the transaction, the insider owned 132,656 shares of the company’s stock, valued at approximately $42,603,800.96. This represents a 20.33% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 120,769 shares of company stock worth $36,428,967 over the last 90 days. 40.90% of the stock is owned by insiders.

About Oracle

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Featured Stories

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCLFree Report).

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.